Hepatic bile acid synthesis is subject to complex modes of transcriptional control, in which the bile acid-activated nuclear receptor farnesoid X receptor (FXR) in liver and intestine-derived, FXR-controlled fibroblast growth factor 15 (Fgf15) are involved. The Fgf15 pathway is assumed to contribute significantly to control of hepatic bile acid synthesis. However, scientific evidence supporting this assumption is primarily based on gene expression data. Using intestine-selective FXR knockout mice (iFXR-KO), we show that contribution of intestinal FXR-Fgf15 signalling in regulation of hepatic cholesterol 7a-hydroxylase (Cyp7A1) expression depends on time of the day with increased hepatic Cyp7A1 expression in iFXR-KO mice compared with controls exclusively during the dark phase. To assess the physiological relevance hereof, we determined effects of intestine-selective deletion of FXR on physiological parameters such as bile formation and kinetics of the enterohepatic circulation of bile acids. It appeared that intestinal FXR deficiency leads to a modest but significant increase in cholic acid pool size, without changes in fractional turnover rate. As a consequence, bile flow and biliary bile acid secretion rates were increased in iFXR-KO mice compared with controls. Feeding a bile acid-containing diet or treatment with a bile acid sequestrant similarly affected bile formation in iFXR-KO and control mice and induced similar changes in Cyp7A1 and Cyp8B1 expression patterns. In conclusion, this study is the first to demonstrate the physiological relevance of the contribution of the intestinal FXR-Fgf15 signalling pathway in control of hepatic bile acid synthesis. Fgf15 contributes to the regulation of hepatic bile acid synthesis in mice mainly during the dark phase. Expansion of the circulating bile acid pool as well as bile acid sequestration diminishes the contribution of intestinal FXR-Fgf15 signalling in control of hepatic bile acid synthesis and bile formation.
Bile acids are synthesized from cholesterol in the liver by at least two well-characterized synthetic cascades, ie, the 'classical' neutral pathway and the 'alternative' acidic pathway. 1 Bile acids serve a variety of important physiological functions in the body. One of the prominent functions of bile acids is in the generation of bile formation in the liver: the biliary pathway is a major route for removal of endo-and xenobiotics as well as of excess cholesterol. 1 Under fasting conditions, bile is stored in the gallbladder. Upon ingestion of a meal, bile is released from the gallbladder and secreted into the intestinal lumen, where bile acids facilitate the digestion and absorption of dietary lipids and fat-soluble vitamins. 1 Approximately 95% of the total bile acid pool will be reabsorbed by specific transporters present in the terminal ileum and transported back to the liver for resecretion into bile, thereby completing the so-called enterohepatic circulation. In this way, a pool of bile acids is maintained that ensures optimal concentrations of these natural detergents at their sites of action. Non-absorbed bile acids (5%) will enter the colon and are either, after being converted into secondary bile acids by bacteria, passively absorbed to enter the pool or disposed from the body through the feces. To compensate for this fecal loss, the liver will synthesize bile acids from cholesterol to maintain bile acid pool size. 1 Apart from their well-known functions in bile formation, cholesterol homeostasis and fat absorption, bile acids are now also known to exert regulatory roles in triglyceride and glucose metabolism. 1 Hence, tight control of bile acid pool size, composition and cycling frequency is of physiological relevance.
During the past years, it has become clear that the farnesoid X receptor (FXR, also known as NR1H4), a bile acid-sensing nuclear receptor, has a key function in the maintenance of bile acid homeostasis. [2] [3] [4] FXR is involved in control of bile acid synthesis in the liver and of bile acid transport through the enterohepatic circulation. This nuclear receptor is expressed in the liver and intestine as well as in other organs and tissues such as adrenals and adipose tissue. 5, 6 Upon its activation, hepatic FXR suppresses bile acid synthesis by transcriptional downregulation of Cyp7A1, 7, 8 the enzyme that catalyzes the first and rate-controlling step in the primary bile acid synthesis cascade. A previous study from our laboratory has demonstrated that FXR-null mice show, as expected, increased hepatic Cyp7A1 gene expression levels. Furthermore, these mice turned out to have an increased cholic acid synthesis rate and an expanded cholic acid pool size. 3 However, apart from the inhibitory actions of activated hepatic FXR, Cyp7A1 is regulated through several other FXR-dependent and -independent mechanisms. Several CLOCK-dependent transcription factors are involved in the maintenance of the circadian expression of Cyp7A1, ie, Dbp, Rev-erba and E4BP4. [9] [10] [11] In addition, an intriguing mode of FXR-mediated control on hepatic Cyp7A1 expression is exerted by indirect signalling from the small intestine. Bile acid-induced activation of intestinal FXR induces expression of murine fibroblast growth factor 15 (Fgf15) 12 and of its human orthologue FGF19. 13 In contrast to most other Fgf proteins, Fgf15/19 has a weak heparin-binding affinity, which enables it to escape from being captured in extracellular matrices. As a consequence, intestine-derived Fgf15 is able to reach the liver and act as an endocrine factor.
14 Upon activation of its hepatic receptor, Fgf receptor isotype 4 (FGFR4), which requires bKlotho as a co-receptor for optimal functionality, Cyp7A1 expression is repressed. 14, 15 Kim et al 16 recently compared bile acid metabolism in liver-and intestine-specific FXR knockout mice to examine the relative contributions of hepatic and intestinal FXR in control of hepatic bile acid synthesis. However, the conclusions of Kim et al 16 are merely based on rather moderate differences at the gene expression level. In this study, we address the relative contribution of the FXR-Fgf15 pathway to hepatic bile acid synthesis not only by examining changes at the gene expression level but, more importantly, also by determining the effect of intestine-selective deletion of FXR on physiological parameters such as bile formation and kinetics of the enterohepatic circulation of bile acids. In addition, the relative contribution of the intestinal FXR-Fgf15 signalling pathway is determined during the modulation of the bile acid pool by bile acid feeding and bile acid sequestration. Fgf15 contributes to the regulation of hepatic bile acid synthesis in mice mainly during the dark phase.
Expansion of the circulating bile acid pool and bile acid sequestration diminishes the contribution of intestinal FXR-Fgf15 signalling in control of hepatic bile acid synthesis and bile formation.
MATERIALS AND METHODS Animals
The intestine-selective FXR knockout mice were generated by cross-breeding of mice with loxP sites flanking the last FXR exon, containing the ligand-binding domain (described by Sinal et al 4 ), with mice harboring cre-recombinase under the control of the villin promoter (Villin-Cre mice 17 ). Animals were maintained on a C57B/6;129 mixed background.
Animals used in this study, male and female homozygous knockout mice (iFXR-KO) and wild-type (WT) littermates, were housed in a light-and temperature-controlled facility and received standard laboratory chow (RMH-B, Abdiets, Woerden, The Netherlands) and water ad libitum. When indicated, the endogenous FXR ligand TCA or the bile acid sequestrant Colesevelam HCl were mixed with the standard laboratory chow. The mice received humane care, and experimental procedures were in accordance with the local guidelines for use of experimental animals. 
Materials

Experimental Procedures
In the first three experiments, mice were fed normal laboratory chow. The patterns of FXR and Fgf15 expression along the small intestine were examined in fed male WT and iFXR-KO mice (N ¼ 3), killed in the morning (0900 hours). The small intestine was rinsed with phosphate-buffered saline (PBS) and divided into six parts: 0, 33, 66, 83, 90 and 100% (relative distance from the stomach to distal ileum). Intestinal segments were frozen in liquid nitrogen and stored at À801C until RNA isolation.
Subsequently, the circadian rhythms of genes involved in hepatic bile acid synthesis were determined in 6-7 female WT and iFXR-KO mice. At 0700, 1300, 1900 and 0100 hours, mice were killed in the fed condition and the livers and terminal ilea were excised, (snap-)frozen and stored at À801C until RNA isolation. mRNA expression levels were analyzed by means of real-time quantitative PCR (see below).
Under isoflurane anesthesia, 300 mg of [ 2 H 4 ]-cholate in a solution of 0.1% NaHCO 3 in PBS (pH ¼ 7.4) was intravenously administered to male WT and iFXR-KO mice (N ¼ 6). Every 12 h (t ¼ 12 till t ¼ 60) a retro-orbital blood sample of about 75 ml was taken. Plasma was obtained by means of centrifugation (4000 r.p.m., 10 min, 41C). At t-60 h, the mice were anesthetized with a mixture of hypnorm (1 ml/kg) and diazepam (10 mg/kg) and subjected during FXR-Fgf15 regulates hepatic BA synthesis JHM Stroeve et al 30 min to bile duct cannulation for the collection of bile. 18 During this collection period, the animals were placed in a humidified incubator to ensure maintenance of body temperature. Subsequently, mice were killed by cardiac puncture and the livers, distal small intestines and terminal ilea were excised. Livers and small intestinal segments were (snap-)frozen in liquid nitrogen and stored at À801C until RNA isolation and biochemical analysis. Feces and urine were collected from individual mice.
To evaluate the effects of supplementing/sequestrating FXR ligands, male WT and iFXR-KO mice (N ¼ 5) were either fed during 3 days the normal laboratory chow enriched with 0.5% taurocholic acid (TCA) or were fed for 7 days normal chow enriched with 2% Colesevelam HCl. At the end of these periods, the mice were subjected to bile duct cannulation. 18 Mice were killed by means of cardiac puncture and the livers, distal small intestines and terminal ilea were excised and (snap-)frozen and stored at À801C until RNA isolation and biochemical analysis. Feces were collected from individual mice.
Analytical Procedures
Livers were homogenized in ice-cold saline. Hepatic and biliary lipids were extracted according to Bligh and Dyer. 19 Commercially available kits (total and unesterified cholesterol, unesterified-free fatty acids and phospholipids (Wako, Neuss, Germany) and triglycerides (Roche, Mannheim, Germany)) were used to determine the lipid profiles in plasma, bile and liver. Bile salt concentrations in plasma, bile and feces were determined by an enzymatic fluorimetric assay. 20 Plasma AST and ALT levels were determined by routine clinical-chemical procedures on a P800 unit of a modular analytics serum work area from Roche Diagnostics (Basel, Switzerland). Histological examination of liver morphology was assessed by hematoxylin/eosin staining of formalin-fixed material by standard procedures.
Steady-State mRNA Levels Determined by Real-Time Quantitative PCR From livers and small intestinal segments, mRNA was isolated using TRI reagent (Sigma). Subsequently, cDNA was synthesized by a reverse transcription procedure using Moloney murine leukemia virus transcriptase and random primers according to manufacturer's protocol. mRNA expression levels were analyzed by means of real-time PCR, amplifying cDNA using appropriate primers and probes. PCR results of the liver and intestine were normalized to 18S mRNA levels. The sequences of the primers and probes of 18S, short heterodimer partner (Shp), cholesterol 7a-hydroxylase (Cyp7A1), sterol 12a-hydroxylase (Cyp8B1), sterol 27-hydroxylase (Cyp27A1), rev-erba (Rev-Erba), ileal bile acid-binding protein (Ibabp), apical sodium-dependent bile salt transporter (Asbt), Na þ -taurocholate co-transporting polypeptide (Ntcp), multidrug resistance-associated protein 2/3 (Mrp2/3), bile salt export pump (Bsep) and ATP binding cassette g5/g8 (Abcg5/g8) have been published (http:// www.LabPediatricsRug.nl). For Fgf15, D site of albumin promoter (albumin D-box)-binding protein (Dbp), E4bp4 (E4bp4), Fgfr4 and b-Klotho (b-Klotho) the primers and probe sequences are listed in Supplementary Table S1 .
Gas Chromatography
To examine biliary bile acid composition, bile acids were converted to their methyl ester/trimethylsilyl derivatives. 21 Bile acid composition was subsequently determined by means of a capillary gas chromatography. The hydrophobicity index was calculated according to Heuman et al.
22
Isotope Dilution Technique The isotope dilution technique has been described in detail by Hulzebos et al. 21 After administration of 300 mg [ 2 H 4 ]-cholate, the enrichment, defined as the increase in M 4 -cholate/M 0 -cholate relative to baseline measurements, was expressed as the natural logarithm of atom percent excess (ln APE) value. By means of the linear decay curves, obtained by linear regression analysis of the decay of ln APE over time for the individual mice, the fractional turnover rate (FTR, fraction of pool lost per day), pool size (mmol/100 g BW) and synthesis rate (mmol/100 g BW/day, determined by multiplying pool size and FTR) of cholate were calculated. The calculation of pool size was performed by using the formula:
In this formula 'a' represents the intercept on the y axis of the regression lines of the individual mice, 'D' is the administered amount of label and 'b' is the isotopic purity.
Statistical Analysis
Results are presented as means ± s.d. Differences between the two groups were determined by the non-parametric MannWhitney U-test. The level of significance for all statistical analyses was set at Po0.05. Analyses were performed using SPSS 16.0 for Windows software (SPSS, Chicago, IL, USA).
RESULTS
Characteristics of Chow-Fed Intestine-Selective Fxr Knockout Mice
The mRNA expression profiles of Fxr and Fgf15 along the small intestine were analyzed by RT-PCR. As shown in Figure 1 , Fxr mRNA expression was, as expected, highest in the distal small intestine of WT mice. Fgf15 was mainly expressed in the distal ileum of WT mice, but its expression pattern did not entirely coincide with Fxr expression. The iFXR-KO mice showed a virtually complete absence in Fxr and a strong reduction (average reduction: 82%) in Fgf15 expression along the intestine. Targets of FXR were analyzed in three instestinal segments (proximal, mid and distal) and were found to be expressed at lower levels in the small intestine of iFXR-KO mice, ie, Ibabp and Ost-a expression increase toward distal direction and in the terminal ileum were decreased 87 and 49% in iFXR-KO mice, respectively (data not shown). Ileal expression of Asbt, known to be not regulated by FXR in the mouse, 4 increases into distal direction without showing differences between both groups. Shp, an important target gene of FXR in liver, turned out to be expressed predominantly in the proximal part of the small intestine in both groups and no difference between iFXR-KO and control mice could be detected.
At 3 months of age, body and liver weights of iFXR-KO mice were significantly lower than those of WT littermates (Table 1) , but liver to body weight ratios were not different between the groups. The observed differences in body and liver weights were consistent, ie, were observed at all ages from 4 to 28 weeks and remained upon feeding with specific diets (data not shown and Supplementary Table S2 ). Apart from a rather moderate TCA-induced increase, no differences were observed in plasma AST and ALT activities between iFXR-KO and control mice (Table 1 and Supplementary Table  S2 ). In addition, no differences were observed in liver morphology between the groups (Figure 2 ). Table 1 furthermore shows that reduced body weight in iFXR-KO mice was not due to decreased food intake. Whole body FXR-deficient mice show elevated plasma lipid levels, 3, 4 with high plasma (HDL) cholesterol and triglyceride levels. In contrast, we did not observe any significant differences in plasma or in hepatic lipid contents between chow-fed WT and iFXR-KO mice (Table 1) .
Time-Dependent Effects of Intestine-Selective Fxr-Deficiency on Hepatic Cyp7A1 and Intestinal Fgf15 Expression Because of the well-known diurnal rhythm of hepatic Cyp7A1 expression, 3, 13, 23 we examined the consequence of intestinal FXR deficiency on diurnal hepatic Cyp7A1 expression at four distinct time points, ie, at 0100, 0700, 1300 and 1900 hours. No differences herein were observed between both sexes (male data not shown).
At the start of the dark period (1900 hours), hepatic Cyp7A1 expression was highest in both groups, as expected Figure 3 ). Only during the night period (1900-0700 hours), Cyp7A1 expression was significantly higher in iFXR-KO mice compared with WT controls. Expression of Cyp8B1, essential for the formation of cholic acid, did not show a clear day-night variation and was not significantly affected in the iFXR-KO mice. Furthermore, no differences were observed in hepatic Fxr and Shp expression between both groups. Observing this time-dependent effect of iFXR-deficiency on Cyp7A1 expression, we questioned whether the absence of intestinal FXR and Fgf15 signalling acts through transcription factors (Dbp, Rev-erba and/or E4bp4) involved in the regulation of the circadian rhythmicity of Cyp7A1 expression. Figure 3 demonstrates that these transcription factors indeed showed a distinct circadian pattern in their expression profile, however, expression patterns were highly similar in both strains. Only Dbp and Rev-erba showed an increased expression in WT mice at a single time point (1900 hours), clearly not providing an explanation for the differences in Cyp7A1 expression. Exploring the circadian rhythm of Fgf15 expression ( Figure 4 ) revealed a peak in Fgf15 expression at 0700 hours. As Fgf15 represses Cyp7A1 expression, the expression profile of intestinal Fgf15 turned out, as expected, to be exactly the reverse to hepatic Cyp7A1 expression. Interestingly, no daynight variation in the expression of Ibabp, a well-established FXR target gene, was found in WT mice. Fgf15 and Ibabp expression were significantly lower in the intestine-selective FXR knockout mice when compared with controls.
Effect of Intestine-Selective Deletion of FXR on Bile Formation and Kinetics of the Enterohepatic Circulation of Bile Acids
As shown in Figure 5a , bile flow was significantly higher in iFXR-KO mice compared with controls. Biliary bile acid, cholesterol and phospholipid concentrations were not significantly different between the groups (data not shown). However, as a consequence of the higher bile flow rate, biliary bile acid and phospholipid output rates were significantly higher in the iFXR-KO mice than in controls. To assess the metabolic basis of altered bile formation, kinetic parameters of the enterohepatic circulation were determined upon intravenous injection of [ 2 H 4 ]-cholate. Figure 6a shows the cholate enrichments in plasma over time. From these regression curves, cholate pool size, FTR and synthesis rate were calculated. Cholate pool size of WT mice was B40% smaller than that of iFXR-KO mice. However, the FTR was not significantly different between the groups. Cholate synthesis rate was calculated by multiplying cholic acid pool size and cholate FTR. Owing to a tendency toward a decreased FTR in iFXR-KO mice, the cholate synthesis rate did not reach a statistical significant difference between both groups. However, total bile acid synthesis as deduced from the fecal loss of bile acids, which equals the hepatic bile acid synthesis rate, was significantly higher in the iFXR-KO mice than in littermate controls (15.0 ± 1.0 mmol/day/100 g BW and 23.6 ± 2.5 mmol/day/100 g BW, WT and iFXR-KO mice, respectively). Table 2 shows that, in addition to altered bile formation, the bile acid composition in bile was affected by intestinal FXR deficiency as well. In bile of iFXR-KO mice, an increased relative contribution of cholic acid and deoxycholic acid was observed, whereas b-and o-muricholic acids, derived from chenodeoxycholic acid, were present at lower levels in bile of these mice. As a consequence of this compositional change, the mean hydrophobicity index of the bile acids in bile was increased in iFXR-KO mice when compared with WT controls.
Supplementary Figure S1 shows no differences in hepatic expression of genes involved in either hepatic FXR or Fgf15 signalling (Fxr, Shp and Fgfr4, bKlotho, respectively), bile acid synthesis (Cyp27A1, chenodeoxycholic acid formation) or hepatobiliary transport (Ntcp (also known as Slc10a1, basolateral uptake of bile acids), Mrp2 and 3 (also known as Abcc2 and 3, biliary anion secretion), Bsep (also known as Abcb11, biliary bile acid secretion) and Abcg5/8 (biliary cholesterol secretion)) were observed.
Effects of Bile Acid Feeding and Bile Acid Sequestration on Bile Formation and Bile Acid Synthesis in Intestine-Selective FXR-KO Mice
Feeding intestine-selective FXR-KO and WT mice a moderately bile acid-enriched diet (TCA; 0.5% w/w for 3 days) was used to increase the circulating bile acid pool. Figure 5 shows that, upon feeding this diet, bile flow tended to increase in both groups. The biliary bile acid, cholesterol and phospholipid output rates were all significantly increased upon TCA feeding. Interestingly, the differences between the two groups observed upon chow feeding were largely diminished in this condition. At the gene expression level, TCA-enriched diet feeding did not change the expression level of intestinal Fxr, however, caused a massive upregulation in Shp (430-fold) and Fgf15 (430-fold) expression in the terminal ileum of control mice. In the liver, there was a relatively small increase in Shp expression, exclusively in iFXR-KO mice. Yet, Figure 7 shows a clear downregulation of Sequestration of bile acids in the intestinal tract by means of a Colesevelam HCl-enriched diet reduced bile flow as well as in biliary bile acid, cholesterol and phospholipids output rates ( Figure 5 ). Significant differences in cholesterol and phospholipids output rates between WT and iFXR-KO mice were observed despite similar bile acid output rates. However, these differences between the two groups were small when compared with the differences observed upon chow feeding. Bile acid sequestration did not change intestinal Shp expression, however, caused a steep decrease in Fgf15 expression. Likely as a consequence hereof, we observed an upregulation in hepatic Cyp7A1 expression in WT mice. Despite the already low expression of Fgf15 in the iFXR-KO mice, we, surprisingly, observed a similar induction of hepatic Cyp7A1 expression in iFXR-KO mice as in WT controls. Cyp8B1 increased in both strains as well, although this did not reach statistical significance in the WT controls. Hepatic Shp expression did not change in iFXR-KO mice, however, was decreased in WT controls, possibly contributing to the observed increases in Cyp7A1 and Cyp8B1 expression.
DISCUSSION
Bile acids exert important physiological functions in control of bile formation, cholesterol homeostasis and fat absorption. In addition, they also exert regulatory roles in triglyceride and glucose metabolism. 1 Maintaining bile acid homeostasis is therefore of great physiological relevance. The bile acidactivated FXR is an important factor in control of bile acid homeostasis. In addition to the established direct hepatic FXR pathway of Cyp7A1 suppression, an indirect intestinal FXR-mediated signalling pathway has been identified. 12, 13 Activation of intestinal FXR increases the expression of Fgf15. Fgf15 travels through the circulation to the liver, where it represses Cyp7A1. The relative importance of direct control by hepatic FXR and indirect FXR-Fgf15-mediated control has remained elusive. Recently, Kim et al 16 addressed this issue by comparing intestine-and liver-selective FXR-KO mice. These authors concluded that repression of Cyp7A1 was more strongly affected by disruption of intestinal FXR, whereas repression of Cyp8B1 was more sensitive to loss of hepatic FXR. 16 This and earlier work 24 led to the general assumption that the intestinal FXR-Fgf15 pathway provides a major contribution to control of hepatic bile acid synthesis. Yet, the scientific evidence supporting this assumption is merely based on rather modest differences at the gene expression level. In contrast to Kim et al, 16 we now focussed on the physiological consequences of intestinal FXR deficiency by assessing the effects on diurnal variation of the bile acid synthesis machinery, on the kinetics of bile acid metabolism and on the bile formation process. We showed that the effect of disrupting intestinal FXR on hepatic Cyp7A1 expression is dependent on the time of the day, with less efficient suppression during the night phase when Fgf15 expression is high in WT mice. The consequences are an increased bile flow and biliary secretion rates of bile acids and phospholipids. By means of a mouse-adapted isotope dilution technique, 21 we showed that the cholic acid pool size is significantly increased in the intestine-selective FXR knockout mice without differences in FTR. Increasing the circulating bile acid pool by means of TCA-enriched diet feeding and withdrawal of bile acids from the pool by sequestration minimized the observed differences between both strains.
We observed a consistent slight decrease in body weight of iFXR-KO mice (B15%), not mentioned by Kim et al. 16 As no differences in food intake or fecal energy content were found (data not shown), this likely reflects alterations in energy expenditure in iFXR-KO mice. This unexpected consequence of iFXR deficiency is currently under investigation.
It is well known that hepatic Cyp7A1 expression displays a pronounced diurnal rhythm. 3, 13, 23 Cyp7A1 expression turned out to be exclusively increased in iFXR-KO mice during the active night period, when Fgf15 expression is high in WT mice. As no differences between both groups were observed 25 Despite the time-dependent effect on Cyp7A1 expression, iFXR-KO mice display an overall increased cholic acid pool size. As a consequence, biliary bile acid secretion was increased which, in turn, led to an increased bile flow and phospholipid output. This is in agreement with results from Yu et al. 26 These authors reported that Fgfr4-deficient mice, thus lacking hepatic Fgf15 signalling, also display an increased bile acid pool size and a higher rate of hepatobiliary bile acid secretion than their controls.
Upon feeding a moderate bile acid-enriched diet, biliary bile acid secretion was increased in both groups, associated with an increased phospholipids and cholesterol secretion. As intestinal FXR is disrupted in iFXR-KO mice, we did not expect to observe a decrease in hepatic Cyp7A1 expression in these mice. However, increasing the bile acid pool led to a downregulation of Cyp7A1, not reaching statistical significance in WT mice, and of Cyp8B1 in both genotypes. The small increase in ileal Fgf15 expression in combination with the increase in hepatic Shp expression might explain the observed decrease in Cyp7A1 expression in the iFXR-KO mice. More importantly, most of the differences between the two strains observed in bile formation were minimized, implying that a rather moderate increase in bile acid flux through the liver ( þ 30%) overrules the regulatory role of intestinal Fgf15.
Upon sequestration of bile acids in the intestinal tract, biliary bile acid secretion decreased in both groups, leading to decreased bile flow and phospholipids and cholesterol Table 2 Bile acid profile in bile of chow-fed wild-type and intestine-selective FXR knockout mice secretion. In accordance with TCA-enriched diet feeding, most of the observed differences between the two strains in the chow-fed condition were minimized. At the gene expression level, bile acid sequestration caused a decrease in intestinal Fgf15 expression resulting in increased hepatic Cyp7A1 and Cyp8B1 mRNA levels. However, in WT mice we cannot exclude the contribution of decreased hepatic Shp expression.
Kim et al 16 concluded that intestinal FXR through Fgf15 primarily regulates the expression of Cyp7A1, whereas Cyp8B1 repression was more sensitive to loss of hepatic FXR. 16 However, the combination of their and our results indicates that some care is required in interpretation of these findings. In our study, 0.5% TCA-enriched diet feeding did not affect hepatic FXR signalling in WT mice, as evidenced by an unchanged hepatic Shp expression. However, this diet substantially decreased Cyp8B1 at the gene expression level. In return, the sequestration of bile acids caused a significant decrease in hepatic FXR signalling in WT mice, as evident from a decreased hepatic Shp expression, without any difference in Cyp8B1 mRNA levels. According to the conclusion of Kim et al, 16 hepatic Cyp8B1 expression should not change upon disruption of intestinal FXR. In our present study, we indeed do not observe differences in Cyp8B1 expression level between both strains; however, we did observe a difference in the relative biliary bile acid composition with a shift toward a more hydrophobic bile acid pool (hydrophobicity index À0.352 and À0.217 in WT and iFXR-KO mice, respectively) due to an increased contribution of hydrophobic bile acids species, such as cholic and deoxycholic acids, pointing to an increased contribution of Cyp8B1 activity to hepatic bile acid synthesis.
Kim et al 16 do not explain why the iFXR-KO mice in their study did not display an increased basal Cyp7A1 mRNA level. We show that this is most likely due to the time-dependent effect of deleting intestinal Fgf15 on hepatic Cyp7A1 expression. With respect to physiology, Kim et al 16 roughly estimated the bile acid pool size by extracting bile acids from freeze-dried liver, gallbladder and small intestine and showed that the total bile acid pool size tended to be increased in iFXR-KO mice compared with controls. By means of the microscale isotope dilution technique, we were able to show that iFXR-KO mice do display a significantly increased cholic acid pool size. This technique furthermore enabled us to examine the kinetic parameters of this bile acid pool: the increased cholic acid pool size appeared to be solely the consequence of an increased hepatic bile acid synthesis rate. A possible contribution of accelerated intestinal bile acid reabsorption could be excluded, as the calculated amount of cholate reabsorbed per day was not different between both strains (data not shown). Turnover and cycling of the bile acid pool occurred similarly in iFXR-KO and control mice, showing no differences in FTR, cycling frequency (pools/day) nor in cycling time (h) (data not shown). As a consequence of the increased cholic acid pool size, biliary bile acid secretion was increased which, in turn, led to an increased bile flow and phospholipid output. In addition, we examined the contribution of intestinal FXR-Fgf15 signalling in control of hepatic bile acid synthesis and bile formation during modulation of the bile acid pool. We show that feeding a bile acid-containing diet or treatment with a bile acid sequestrant similarly affects bile formation in iFXR-KO and control mice and induced similar changes in Cyp7A1 and Cyp8B1 expression patterns.
From our present study we conclude that intestinal FXRmediated Fgf15 production contributes to hepatic bile acid synthesis mainly during the dark period, when intestinal FXR activity is high. The disruption of intestinal FXR results in an increased cholic acid pool size leading to increased biliary bile acid secretion and therefore increased bile flow and phospholipids secretion. Modulation of the bile acid pool either by supplementation or sequestration of bile acids in the intestinal tract minimized the role of intestinal FXR-Fgf15 signalling present under normal dietary conditions.
